Feasibility and Effects of Home-based Physical Activity Intervention in Patients With Breast Cancer in Indonesia
Move to Improve: Investigating the Feasibility of Embedding Physical Activity Into Routine Breast Cancer Care in Indonesia
1 other identifier
interventional
36
1 country
1
Brief Summary
The goal of this clinical trial is to learn the impact and implementation of home-based aerobic and resistance training for patients with breast cancer in Indonesia. The main questions it aims to answer are:
- Does the home-based aerobic and resistance training improve physical fitness, fatigue, and quality of life of patients with breast cancer?
- Are the benefits of aerobic and resistance training mediated by inflammatory level changes?
- What are the barriers and facilitators in implementing the home-based aerobic and resistance training?
- Is the home-based aerobic and resistance training feasible to be implemented in Indonesia's setting? To answer those questions, participants will:
- Conduct home-based aerobic and resistance training with supervision.
- Visit the hospital once every 4 weeks for their routine visits.
- Undergo physical fitness test before and after 12 weeks using treadmill test, as well as interviews to assess fatigue, quality of life, and intervention acceptability.
- Keep a diary to record the aerobic and resistance training at home.
- Undergo routine monitoring by phone every week with the research team.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2024
CompletedFirst Submitted
Initial submission to the registry
January 4, 2026
CompletedFirst Posted
Study publicly available on registry
January 14, 2026
CompletedJanuary 14, 2026
January 1, 2026
9 months
January 4, 2026
January 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Physical fitness
Physical fitness was measured using a submaximal treadmill test with the modified Bruce protocol. Treadmill speed and inclination were automatically increased every 3 min (test stage). The test was terminated when participants reached volitional fatigue. Physical fitness was classified as low, fair, average, and good, based on patients' age, treadmill test duration, and predicted VO2peak.
Baseline and post-intervention (12 weeks)
Fatigue
Fatigue was assessed using the Indonesian version of Fatigue Severity Scale (FSS). A higher score on the FSS indicated a more severe level of fatigue. The FSS was also classified as no-to-mild fatigue (FSS \<4.0) and severe fatigue (≥4.0).
Baseline and post-intervention (12 weeks)
Health-related quality of life
Health-related quality of life was assessed using the Indonesian version of the EORTC Quality of Life Questionnaire (QLQ-C30). The EORTC QLQ-C30 consists of global health status, functional scales, and symptom scales. A higher score indicates better health for global health status and functional scales, but represents a higher level of burden for symptom scales.
Baseline and post-intervention (12 weeks)
Secondary Outcomes (3)
Inflammatory biomarkers
Baseline and post-intervention (12 weeks)
Intervention acceptability
Post-intervention (12 weeks)
Intervention barriers and facilitators
Post-intervention (12 weeks)
Other Outcomes (2)
Intervention feasibility
During study period (baseline to 12 weeks)
Adverse events
During study period (baseline to 12 weeks)
Study Arms (1)
Physical activity intervention
EXPERIMENTALInterventions
1. Home-based aerobic training: The aerobic exercise consisted of a walking program based on the number of steps per day, which was recorded using a pedometer (Yamax Digiwalker SW-200, Tokyo, Japan). The target of the aerobic exercise was individually tailored by adding 3000 accumulated steps above their baseline value on 5 days of the week. 2. Home-based resistance training: The resistance training was conducted using a set of resistance bands (Happy Fit®, Jakarta, Indonesia). This training consisted of two sets of biceps curl, triceps extension, chest press, shoulder flexion, shoulder press, lateral extension, seated row, and upright row, with 8-10 repetitions. Patients were instructed to perform each exercise with an average total duration of 10 minutes on 2 days a week at home. The exercises were individually tailored based on participants' strength and range of movement using a set of three color-coded bands representing low, moderate, and high levels of resistance.
Eligibility Criteria
You may qualify if:
- Patients with stage I-III hormone-receptor positive breast cancer
- Eastern Cooperative Oncology Group (ECOG) score ≤1
- Had completed primary treatment (e.g., surgery, chemotherapy, and radiotherapy), except for hormonal treatment
- Within 5 years of diagnosis
- Able to perform moderate-intensity physical activity as determined by their oncologist and care team
- Able to read and write in Indonesian
- Willing to provide written informed consent.
You may not qualify if:
- Had an ejection fraction of \<50%
- Evidence of cardiac disease, severe musculoskeletal problems, or other contraindications for exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leedscollaborator
- Durham Universitycollaborator
- Gadjah Mada Universitylead
Study Sites (1)
Dr. Sardjito General Hospital
Sleman, Yogyakarta Special Region, 55284, Indonesia
Related Publications (6)
Leite VF, Cecatto RB, Battistella LR, de Brito CMM. Establishing a Cancer Rehabilitation Service in a Middle-Income Country: an Experience from Brazil. Curr Phys Med Rehabil Rep. 2022;10(4):339-344. doi: 10.1007/s40141-022-00373-4. Epub 2022 Nov 28.
PMID: 36466557BACKGROUNDBatalik L, Winnige P, Dosbaba F, Vlazna D, Janikova A. Home-Based Aerobic and Resistance Exercise Interventions in Cancer Patients and Survivors: A Systematic Review. Cancers (Basel). 2021 Apr 15;13(8):1915. doi: 10.3390/cancers13081915.
PMID: 33921141BACKGROUNDde Jesus Leite MAF, Puga GM, Arantes FJ, Oliveira CJF, Cunha LM, Bortolini MJS, Penha-Silva N. Effects of combined and resistance training on the inflammatory profile in breast cancer survivors: A systematic review. Complement Ther Med. 2018 Feb;36:73-81. doi: 10.1016/j.ctim.2017.11.023. Epub 2017 Dec 1.
PMID: 29458936BACKGROUNDLahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity for women with breast cancer after adjuvant therapy. Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD011292. doi: 10.1002/14651858.CD011292.pub2.
PMID: 29376559BACKGROUNDMcNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006 Jul 4;175(1):34-41. doi: 10.1503/cmaj.051073.
PMID: 16818906BACKGROUNDAstari YK, Hutajulu SH, Fitriani Z, Mozhaf MDLQ, Paramita DK, Wibowo RA, Sofia NA, Hartopo AB, Hardianti MS, Purwanto I, Burke S. The changes of inflammatory biomarkers after a 12-week home-based aerobic and resistance exercise intervention in breast cancer survivors. BMC Res Notes. 2026 Mar 28. doi: 10.1186/s13104-026-07764-z. Online ahead of print. No abstract available.
PMID: 41904552DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanna H Hutajulu, MD, PhD
Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital
- STUDY CHAIR
Shaunna Burke, PhD
Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Susanna Hilda Hutajulu, MD, PhD
Study Record Dates
First Submitted
January 4, 2026
First Posted
January 14, 2026
Study Start
January 3, 2022
Primary Completion
October 13, 2022
Study Completion
February 5, 2024
Last Updated
January 14, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
The IPD that underlie results in the publication are accessible from the corresponding author upon reasonable request and subject to applicable data sharing agreements and approval processes.